Expression of Erythroid Differentiation Regulator 1 (Erdr1) in Vitiligo

Cairo University (CU)

Status: Unknown

Conditions: Erythroid Differentiation Regulator 1 (Erdr1) Cytokine

Treatments: Other: skin biopsy

Study type: Interventional

Funder types: Other

Identifiers

NCT03377998

Dermatology 4

Details and patient eligibility

About

Expression of Erythroid differentiation regulator 1 (Erdr1) cytokine in vitiligo

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients with generalized non-segmental vitiligo.
• Both sexes.
• Age >18 years old.
• New cases or cases not receiving any medication for at least 3 months ago.

Exclusion criteria

• Segmental or Universal vitiligo
• Autoimmune diseases

Trial design

Primary purpose: Health Services Research

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

100 participants in 2 patient groups

vitiligo patients

Experimental group

Description:

lesional skin biopsy to measure ERDR1 level

Treatment:

Other: skin biopsy

controls

Experimental group

Description:

normal skin biopsy to measure ERDR1 level

Treatment:

Other: skin biopsy